Saturday, January 03, 2026 | 04:16 AM ISTहिंदी में पढें
Medicamen Biotech Ltd
Board Meeting Intimation for Consideration Of Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half Year Ended On September 30 2025
04:37 PM, 5th Nov 2025
Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited Financial Results of the Company for the quarter and half year ended on September 30 2025.
